MAURELLI, MARTINA
 Distribuzione geografica
Continente #
NA - Nord America 695
EU - Europa 544
AS - Asia 114
OC - Oceania 3
SA - Sud America 2
Totale 1.358
Nazione #
US - Stati Uniti d'America 689
IE - Irlanda 133
SE - Svezia 108
GB - Regno Unito 97
FR - Francia 96
CN - Cina 91
IT - Italia 50
DE - Germania 21
UA - Ucraina 13
FI - Finlandia 7
NL - Olanda 7
IN - India 6
BE - Belgio 5
MX - Messico 4
AU - Australia 3
ID - Indonesia 3
VN - Vietnam 3
CA - Canada 2
IR - Iran 2
KR - Corea 2
RO - Romania 2
SG - Singapore 2
TH - Thailandia 2
BR - Brasile 1
CL - Cile 1
HK - Hong Kong 1
HR - Croazia 1
IL - Israele 1
JP - Giappone 1
LU - Lussemburgo 1
PL - Polonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.358
Città #
Chandler 244
Dublin 121
Southend 87
Jacksonville 42
Lawrence 34
Princeton 34
Wilmington 28
Woodbridge 19
Washington 18
Verona 17
Ashburn 15
Beijing 15
Jinan 14
Ann Arbor 10
Houston 10
Bologna 9
Nanjing 8
Redwood City 8
Fairfield 7
Helsinki 6
Boydton 5
Brussels 5
Redmond 5
Seattle 5
Shenyang 5
Changsha 4
Ghaziabad 4
Hanover 4
Hebei 4
Jiaxing 4
Nanchang 4
Amsterdam 3
Dearborn 3
Esslingen am Neckar 3
Fuzhou 3
Guangzhou 3
Hangzhou 3
Ningbo 3
Norwalk 3
Oullins 3
Tianjin 3
Zhengzhou 3
Bangkok 2
Binasco 2
Cambridge 2
Chicago 2
Florence 2
Gangbuk-gu 2
Guadalajara 2
Haikou 2
Le Mans 2
Leawood 2
Legnago 2
Lugo 2
Malang 2
Menlo Park 2
Monterrey 2
Phoenix 2
Taiyuan 2
Taizhou 2
Tappahannock 2
Toronto 2
Andover 1
Atlanta 1
Bacau 1
Bari 1
Belgrade 1
Boston 1
Bratislava 1
Büdelsdorf 1
Canberra 1
Chaoyang 1
Clearwater 1
Dong Ket 1
Edinburgh 1
Evanston 1
Fremont 1
Grezzana 1
Jerusalem 1
Kagoshima 1
Kettering 1
Kunming 1
London 1
Luxembourg 1
Makassar 1
Melbourne 1
New York 1
Odesa 1
Paris 1
Parsippany 1
Pieve di Soligo 1
Saint Louis 1
San Diego 1
Shanghai 1
Simi Valley 1
Staten Island 1
Sydney 1
São Paulo 1
Warsaw 1
Zagreb 1
Totale 906
Nome #
null 80
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study 74
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 50
Primary Cutaneous CD4+ Small/Medium Pleomorphic T-Cell Lymphoproliferative Disorder: A Case Series 48
Amicrobial Pustulosis of the Folds: Report of Three New Cases 47
Neutrophilic figurate erythema: report of a new case in an adult and comparison between adult and paediatric cases 44
Psoriasin (S100A7) is increased in serum of patients with moderate to severe psoriasis 44
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 44
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 43
Interferon-beta injection site reactions in patients with multiple sclerosis. 42
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 41
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 41
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo 40
Idiopathic lichenoid and granulomatous dermatitis 40
A systematic review of treatments for pityriasis lichenoides 38
Severe cutaneous aluminum reaction to quadrivalent human papillomavirus vaccine treated with cyclosporin 37
Adrenergic urticaria successfully treated with omalizumab 36
Annually Recurring Erythema Annulare Centrifugum: A New Case Series with Review of the Literature 35
Biological agents targeting interleukin-13 for atopic dermatitis 34
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 32
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 32
Annular Erythema: New and Revisited Variants 32
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 31
Milia-like calcinosis cutis in Down syndrome: a new case with a review of the literature 31
A case of genital primary syphilis with superimposed impetigo 28
Clinical profile and co-infections of urethritis in males 28
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 28
Palisaded neutrophilic granulomatous dermatitis and its associations with autoimmune diseases 26
Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients 25
Lichen planopilaris coexisting with plaque psoriasis effectively treated with brodalumab 24
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 22
Visual Vignette 21
The emerging role of the neuroimmune cytokine interleukin-31 in chronic inflammatory skin diseases 20
Pruritus as a Distinctive Feature of Type 2 Inflammation 20
Targeting IL-4 for the Treatment of Atopic Dermatitis 20
A man with a widespread bullous eruption 18
Lymphoplasmacytic plaque effectively treated with imiquimod 15
Uncommon Non‑Infectious Annular Dermatoses 14
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 13
Variations of symptoms of atopic dermatitis and psoriasis in relation to menstrual cycle 12
Eosinophilic annular erythema successfully treated with cyclosporine 11
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 11
Advanced Glycation End Products and Psoriasis 10
Advanced Glycation End Products are Increased in the Skin and Blood of Patients with Severe Psoriasis 9
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 8
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 6
Tailored biological treatment for patients with moderate-to-severe psoriasis 6
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 4
Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience 3
Overview of Atopic Dermatitis in Different Ethnic Groups 2
The Combination of Dupilumab with Other Monoclonal Antibodies 2
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 1
Totale 1.423
Categoria #
all - tutte 5.637
article - articoli 5.517
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 120
Totale 11.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201938 0 0 13 2 3 6 9 0 0 4 1 0
2019/202092 7 2 1 0 21 10 2 2 5 13 16 13
2020/2021127 13 13 3 21 19 16 10 1 6 2 13 10
2021/2022228 13 26 0 18 31 6 6 23 4 14 30 57
2022/2023747 38 68 63 134 58 187 18 34 93 16 26 12
2023/202492 17 30 45 0 0 0 0 0 0 0 0 0
Totale 1.423